Bacteremia and fungemia in the immunocompromised patient

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
T E Kiehn

Abstract

Considerable changes have occurred during the 1980s in the clinical nature and diagnosis of bacteremia and fungemia in the immunocompromised patient. Cancer patients with prolonged neutropenia, many with indwelling catheters, and AIDS patients with both T-cell and B-cell deficiencies have changed the spectrum of organisms causing septicemia. There has been a shift to infection with gram-positive bacteria, including mycobacteria, and water-borne organisms, including Acinetobacter spp. and Pseudomonas spp. New blood culture systems, including a lysis-centrifugation system and radiometric methods utilizing resin broth media, remove antagonistic antimicrobial agents, and the lysis-centrifugation system routinely provides quantitation of organisms from the blood. Quantitation has been used to identify sources of infection, to differentiate contamination from true infection, and to monitor the course of antibiotic treatment.

References

Apr 1, 1979·Archives of Internal Medicine·E J WingA Winkelstein
Jan 1, 1978·Medical and Pediatric Oncology·P A PizzoA S Levine
May 1, 1977·The American Journal of Medicine·C SingerD Armstrong
Aug 1, 1988·Journal of Clinical Microbiology·F G WitebskyS H Siddiqi
Jan 1, 1986·Diagnostic Microbiology and Infectious Disease·B E HirshD Armstrong
Nov 1, 1986·Diagnostic Microbiology and Infectious Disease·J M JandaT Robin
Dec 1, 1987·European Journal of Clinical Microbiology·W Kern, E Vanek
Apr 1, 1986·Annals of Internal Medicine·E WhimbeyD Armstrong
Nov 1, 1986·Journal of Clinical Microbiology·P Brannon, T E Kiehn
Feb 1, 1987·European Journal of Clinical Microbiology·J FreneyJ Fleurette
Jun 1, 1987·Journal of Clinical Microbiology·J FreneyJ Fleurette
Jun 1, 1985·European Journal of Clinical Microbiology·G PinonY de Rautlin de la Roy
Jul 1, 1984·Annals of Internal Medicine·I NachamkinR M Smibert
Jul 1, 1984·Medicine·O W PressR O Hickman
Jun 25, 1983·British Medical Journal·H FriisK Lind
May 1, 1983·Journal of Clinical Microbiology·R B Schifman, K J Ryan
Jun 1, 1984·American Journal of Clinical Pathology·B R Tegtmeier, J L Vice
Aug 1, 1982·American Journal of Diseases of Children·E D ShapiroK N Spiegelman
Jun 1, 1980·Archives of Internal Medicine·C GandolaS Beard
Aug 1, 1965·Archives of Internal Medicine·G P BODEYE J FREIREICH

❮ Previous
Next ❯

Citations

Dec 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T E Kiehn, D Armstrong
Jul 30, 2008·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasPo-Ren Hsueh
Sep 1, 1995·Mycoses·M PerducaG Filice
Jun 17, 2011·Journal of Clinical Microbiology·Christopher D PfeifferBarbara D Alexander
Mar 8, 2011·Journal of Translational Medicine·Thomas E IchimNeil H Riordan
Apr 1, 1991·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·S Curtas, K Tramposch
Jan 1, 1991·Scandinavian Journal of Infectious Diseases·H NielsenB Bruun
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·M A VictorM M Hansen
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·M ArpiB Bruun
Jan 1, 1992·Scandinavian Journal of Infectious Diseases·P J JohanssonB Ursing
Oct 1, 1993·Clinical Microbiology Reviews·E Reiss, C J Morrison
Mar 1, 1991·Journal of Clinical Microbiology·M BernhardtR F Schell
Oct 1, 1996·Journal of Clinical Microbiology·W C HellingerF R Cockerill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
H L Rieder
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Stephan PolterauerLukas Hefler
© 2022 Meta ULC. All rights reserved